Procyon Advisors LLC cut its position in shares of Procter & Gamble Company (The) (NYSE:PG - Free Report) by 34.2% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 43,152 shares of the company's stock after selling 22,433 shares during the quarter. Procyon Advisors LLC's holdings in Procter & Gamble were worth $6,875,000 as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Northern Trust Corp boosted its holdings in Procter & Gamble by 0.8% during the first quarter. Northern Trust Corp now owns 29,644,000 shares of the company's stock worth $5,051,930,000 after purchasing an additional 248,792 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its holdings in Procter & Gamble by 13.0% during the first quarter. Price T Rowe Associates Inc. MD now owns 21,480,670 shares of the company's stock worth $3,660,737,000 after purchasing an additional 2,466,308 shares during the last quarter. Goldman Sachs Group Inc. boosted its holdings in Procter & Gamble by 3.5% during the first quarter. Goldman Sachs Group Inc. now owns 17,405,539 shares of the company's stock worth $2,966,252,000 after purchasing an additional 583,629 shares during the last quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC boosted its holdings in Procter & Gamble by 6.3% during the first quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 17,293,428 shares of the company's stock worth $2,947,146,000 after purchasing an additional 1,018,865 shares during the last quarter. Finally, Royal Bank of Canada boosted its stake in Procter & Gamble by 0.6% in the first quarter. Royal Bank of Canada now owns 17,273,679 shares of the company's stock valued at $2,943,779,000 after acquiring an additional 111,162 shares during the last quarter. 65.77% of the stock is currently owned by hedge funds and other institutional investors.
Procter & Gamble Stock Up 0.8%
Shares of NYSE PG opened at $158.08 on Wednesday. The company has a current ratio of 0.70, a quick ratio of 0.49 and a debt-to-equity ratio of 0.49. Procter & Gamble Company has a 12 month low of $149.91 and a 12 month high of $180.43. The firm has a market capitalization of $369.98 billion, a PE ratio of 24.28, a price-to-earnings-growth ratio of 4.14 and a beta of 0.36. The firm has a fifty day simple moving average of $156.14 and a two-hundred day simple moving average of $161.62.
Procter & Gamble (NYSE:PG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 29th. The company reported $1.48 EPS for the quarter, topping the consensus estimate of $1.42 by $0.06. Procter & Gamble had a net margin of 18.95% and a return on equity of 32.69%. The business had revenue of $20.89 billion during the quarter, compared to analyst estimates of $20.79 billion. During the same period in the prior year, the business earned $1.40 EPS. The company's revenue for the quarter was up 1.7% on a year-over-year basis. Procter & Gamble has set its FY 2026 guidance at 6.830-7.090 EPS. Equities analysts expect that Procter & Gamble Company will post 6.91 earnings per share for the current year.
Procter & Gamble Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, August 15th. Shareholders of record on Friday, July 18th were issued a $1.0568 dividend. The ex-dividend date was Friday, July 18th. This represents a $4.23 annualized dividend and a yield of 2.7%. Procter & Gamble's dividend payout ratio is 64.98%.
Analysts Set New Price Targets
A number of research analysts have weighed in on PG shares. UBS Group set a $180.00 target price on shares of Procter & Gamble and gave the company a "buy" rating in a research note on Wednesday, July 30th. Wells Fargo & Company dropped their target price on shares of Procter & Gamble from $175.00 to $173.00 and set an "overweight" rating on the stock in a research note on Wednesday, July 30th. Barclays set a $164.00 target price on shares of Procter & Gamble and gave the company an "equal weight" rating in a research note on Thursday, July 31st. Evercore ISI reiterated an "in-line" rating and issued a $170.00 target price (down from $190.00) on shares of Procter & Gamble in a research note on Monday, July 14th. Finally, BNP Paribas reiterated an "outperform" rating and issued a $177.00 target price on shares of Procter & Gamble in a research note on Friday, August 15th. One equities research analyst has rated the stock with a Strong Buy rating, ten have issued a Buy rating and seven have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has a consensus rating of "Moderate Buy" and a consensus target price of $175.12.
Get Our Latest Stock Report on Procter & Gamble
Insider Buying and Selling
In related news, CEO Gary A. Coombe sold 10,194 shares of the stock in a transaction dated Thursday, August 21st. The shares were sold at an average price of $158.16, for a total value of $1,612,283.04. Following the completion of the transaction, the chief executive officer directly owned 34,978 shares in the company, valued at $5,532,120.48. This trade represents a 22.57% decrease in their position. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this hyperlink. Also, COO Shailesh Jejurikar sold 13,039 shares of the stock in a transaction dated Tuesday, August 19th. The stock was sold at an average price of $157.27, for a total transaction of $2,050,643.53. Following the completion of the transaction, the chief operating officer owned 28,036 shares of the company's stock, valued at approximately $4,409,221.72. The trade was a 31.74% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 120,181 shares of company stock worth $18,918,012 over the last 90 days. Corporate insiders own 0.20% of the company's stock.
Procter & Gamble Company Profile
(
Free Report)
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Further Reading
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Procter & Gamble Company (The) (NYSE:PG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider Procter & Gamble, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Procter & Gamble wasn't on the list.
While Procter & Gamble currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Explore Elon Musk’s boldest ventures yet—from AI and autonomy to space colonization—and find out how investors can ride the next wave of innovation.
Get This Free Report